Study to Assess the Safety and Biological Activity of AMX0035 for the Treatment of Alzheimer's Disease
Clinical trial NCT03533257 · COMPLETED
Trial details
- NCT number
- NCT03533257
- Sponsor
- Amylyx Pharmaceuticals Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-09-14
- Primary completion
- 2020-10-22
- Enrollment
- 95
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.